Clinical Trial Update: DNA Repair Genes and Outcomes in Patients With Stage III NSCLC

View source ↗

Summary

A clinical trial update examining how DNA repair gene status relates to outcomes in patients with stage III non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Carcinoma, Non-Small-Cell Lung, Chemotherapy | Status: UNKNOWN